These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Implementation of clinical practice policy on the continuous intravenous administration of amphotericin B deoxycholate. Maharom P; Thamlikitkul V J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S118-24. PubMed ID: 17718252 [TBL] [Abstract][Full Text] [Related]
28. Lipid-based formulations of amphotericin B. Plotnick AN J Am Vet Med Assoc; 2000 Mar; 216(6):838-41. PubMed ID: 22570893 [No Abstract] [Full Text] [Related]
29. [Adverse effects and safety of antimicrobial agents--nephrotoxicity]. Sakamoto M Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():605-8. PubMed ID: 17455689 [No Abstract] [Full Text] [Related]
30. Drugs for treatment of systemic fungal infections. Med Lett Drugs Ther; 1984 Mar; 26(658):36-8. PubMed ID: 6321929 [No Abstract] [Full Text] [Related]
31. Drugs for treatments of systemic fungal infections. Med Lett Drugs Ther; 1982 Apr; 24(606):36-8. PubMed ID: 6281635 [No Abstract] [Full Text] [Related]
32. The nephrotoxicity of antimicrobial agents (third of three parts). Appel GB; Neu HC N Engl J Med; 1977 Apr; 296(14):784-7. PubMed ID: 320483 [No Abstract] [Full Text] [Related]
34. Current and future chemotherapy of central nervous system fungal infections. Utz JP Adv Neurol; 1974; 6():127-32. PubMed ID: 4480013 [No Abstract] [Full Text] [Related]
35. Study of renal safety in amphotericin B lipid complex-treated patients. Alexander BD; Wingard JR Clin Infect Dis; 2005 May; 40 Suppl 6():S414-21. PubMed ID: 15809928 [TBL] [Abstract][Full Text] [Related]